Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fat: It isn’t always bad for the heart

02.03.2004


Unwanted fat may have a bigger effect on the heart than physicians previously thought.



Researchers at the Indiana University School of Medicine have discovered that cells in human fat actually may help the body grow new blood vessels to repair both muscle and heart tissue. These cells, called stromal cells, are immature fat cells. Their findings are reported in the March 1 online issue of Circulation, the scientific journal of the American Heart Association.

Jalees Rehman, M.D., principal author of the paper and a fellow at IU’s Krannert Institute of Cardiology and the Indiana Center for Vascular Biology and Medicine, said fat may be a "renewable resource" for individuals with poor circulation. Although he does not promote obesity, Dr. Rehman said stromal cells have properties that can have a therapeutic effect on individuals with heart disease, chronic angina, leg cramping and other conditions caused by poor circulation.


"A lot of people can grow their own blood vessels and when they have blockages in their arteries, their bodies naturally compensate," said Dr. Rehman. "People who cannot grow blood vessels are the ones who may benefit from this research. An example would be individuals who have severe chest pains from angina, which is caused by reduced blood flow to the heart."

Another key group of individuals that could benefit from delivery of their own readily available stromal cells are those with legs cramps or those who are facing leg amputations due to poor circulation, said Dr. Rehman.

Fat contains large numbers of stromal cells, which have stem cell-like properties, said Keith L. March, M.D., Ph.D., principal investigator of the study and director of the Indiana Center for Vascular Biology and Medicine and Cryptic Masons Medical Research Foundation Professor.

Stem cells are nature’s building blocks for tissue and are most commonly found for medical purposes in bone marrow and umbilical cord blood. In addition to their stem cell-like properties, stromal cells in fat tissue make significant amounts of growth factors that enhance angiogenesis, the natural growth of blood vessels.

Drs. Rehman, March and the IU team identified several growth factors found in the stromal cells which cause the angiogenic effect.

Scientists worldwide are actively seeking factors that control angiogenesis to develop treatments for heart disease, stroke and dementias. Cancer researchers also are interested in controlling angiogenesis to stop the growth of blood vessels that feed malignant tumors.

"Of particular interest to the team was the way we predict the cells will react in the body," said Dr. March. "These cells release even more growth factors when placed in low oxygen conditions similar to those experienced by patients with poor circulation."

Dr. Rehman said the team called the cells "intelligent factories" because they can sense a need for more blood vessels and begin "manufacturing" the substances necessary to make those vessels.

"Instead of treating patients with a single growth factor, you could treat them by strategically placing their own stromal cells which respond to low oxygen and adapt to that need," said Dr. Rehman.

"For instance, if an individual who has impaired blood flow to the heart climbs a flight of stairs every day, his body will sense a need for more oxygen to the heart and the stromal cells would respond by releasing more growth factors."

"The process wouldn’t work overnight but with time they would produce needed blood vessels to supply oxygen to the heart or to the legs," said Dr. March. "Stromal cell treatment ideally would allow the bodies of individuals with impaired circulation to compensate in the same way as the bodies of people who can grow their own blood vessels."

Other than the obvious health advantages, patients may find the treatment beneficial because the easiest way to collect the stromal cells is through standard liposuction. Patients may find the treatment slimming long before they gain the cardiovascular health to make workouts feasible.

Mary Hardin | EurekAlert!
Further information:
http://newsinfo.iu.edu/

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>